News

In the first of the two studies, results showed that Merck/Schering-Plough’s Vytorin (ezetimibe/simvastatin) was better than Lipitor (atorvastatin calcium) at lowering LDL, or ‘bad’, cholesterol across the dosing

In this trial, vascular endothelial growth factor-2 (VEGF-2) in the form of ‘naked’ plasmid DNA was delivered in defined doses by direct injection into the heart muscle. Results

The study, part of Boehringer Ingelheim’s ongoing clinical development program to assess the therapeutic potential of pramipexole for the treatment of restless legs syndrome (RLS), demonstrated that a

Previous studies have demonstrated that tetrabenazine improves the symptoms associated with a number of hyperkinetic movement disorders, which include Huntington’s disease, other choreas and tardive dyskinesia. Clinical study

The revelation comes after The Dutch Association of Insurers instructed its members, which include major internationals Aegon NV and ING Groep NV, to draw up policies that cater

The trial, named STEP, was a double-blind, placebo-controlled trial, in which pulmonary arterial hypertension (PAH) patients treated with Tracleer, an oral endothelin receptor antagonist, were randomized to receive

BAY 43-9006, a novel RAF kinase and VEGFR inhibitor under investigation for the treatment of different types of cancer, combines two anticancer activities: inhibition of tumor cell proliferation

The approval covers Remodulin (treprostinil sodium) injection for subcutaneous treatment of class III primary pulmonary hypertension patients. The approval letter did not request any additional clinical trials of

The clinical research organization (CRO) will project manage a new trial that seeks to produce data suitable for an application seeking marketing approval in the US and elsewhere